Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2007Cited by 2.3k
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal CancerDavid G. Pfister, Gregory T. Wolf, Arlene A. Forastiere et al.|Journal of Clinical Oncology|2006Cited by 504
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2023Cited by 163
Circulating Tumor Cells as Potential Biomarkers in Bladder CancerAjjai Alva, Pamela L. Paris, Terence W. Friedlander et al.|The Journal of Urology|2015Cited by 88